New coaching program helps cancer patients tackle nerve pain their way

NCT ID NCT06736600

Completed Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed pilot study tested a behavioral program called PIVOT in 33 adults with chemotherapy-induced peripheral neuropathy. Participants worked with coaches to set personal health goals using a structured goal-setting method. The study aimed to see if this approach is safe and feasible, as part of a larger effort to shift from disease-focused care to whole-person care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Goal-setting tele-coaching and Patient Priorities Care framework
What this could lead to: If successful, this approach could help patients manage chemotherapy-related nerve pain by focusing on what matters most to them.
What could go wrong: This is a small, early feasibility pilot with only 33 participants. It tests a behavioral intervention, not a drug, so benefits may be modest and not generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chemotherapy-induced neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY

Contacts and locations

Locations

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.